Bausch + Lomb Reports Mixed Q2 Results and Raises Revenue Guidance
Bausch Health Companies Inc., parent company of Bausch + Lomb, reported mixed second-quarter results with non-GAAP earnings per share (EPS) coming in below expectations. The firm posted a Non-GAAP EPS of $0.15 for the quarter, missing estimates by $0.01. However, revenue reached $1.39 billion, surpassing forecasts by $20 million and growing 8.6% year-over-year. The company raised its full-year outlook for 2024, projecting total revenue between $5.44 billion to $5.54 billion—up from the previous range of $5.42 billion to $5.52 billion. The updated guidance also includes constant-currency growth expectations of 5.8% to 7.7%, compared to a prior forecast of 5.3% to 7.2%. This revised outlook exceeds analyst consensus estimates, signaling confidence in the company's performance and market position.
Tickers: $BLCO
Topics: Earnings Outlook Update Revenue Beat